AKT1 and familial dilated cardiomyopathy: In comparison with the rats with DCM, CEPO treatment further increased the p-PI3K (p85) and p-Akt (Ser/Thr) protein expression levels in the myocardial cells, in a dose-dependent manner (P<0.05).